IP Library Granted Patent US 7,518,034
Granted Patent B2
US 7,518,034 · App. 10/927,641 · Granted Apr 14, 2009

Compositions and methods for the modification of gene expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,518,034
App. No.
10/927,641
Granted
Apr 14, 2009
Kind
B2
Abstract

Novel isolated plant polynucleotide promoter sequences are provided, together with genetic constructs comprising such polynucleotides. Methods for using such constructs in modulating the transcription of DNA sequences of interest are also disclosed, together with transgenic plants comprising such constructs.

Claims (24)

1. An isolated polynucleotide comprising a sequence selected from the group consisting of:

(a) a sequence recited in SEQ ID NO: 117, wherein the polynucleotide has arabinogalactan promoter activity;

(b) a sequence recited in SEQ ID NO: 107, wherein the polynucleotide has arabinogalactan promoter activity; and

(c) a sequence comprising the E. grandis arabinogalactan promoter contained in SEQ ID NO: 117 or SEQ ID NO: 107, wherein the polynucleotide has arabinogalactan promoter activity.

2. A genetic construct comprising a polynucleotide of claim 1 .

3. A genetic construct comprising, in the 5′-3′ direction:

(a) a promoter sequence;

(b) a DNA sequence of interest; and

(c) a gene termination sequence, wherein the promoter sequence comprises an isolated polynucleotide of claim 1 .

4. The genetic construct of claim 3 , wherein the DNA sequence of interest comprises an open reading frame encoding a polypeptide of interest.

5. A transgenic plant cell comprising a genetic construct of claim 3 .

6. A plant or a part or propagule or progeny thereof comprising a transgenic cell of claim 5 .

7. A method for modifying gene expression in a target plant comprising stably incorporating into the genome of the plant a genetic construct according to claim 3 .

8. A method for producing a plant having modified gene expression comprising:

(a) transforming a plant cell with a genetic construct to provide a transgenic cell, wherein the genetic construct comprises: (i) a promoter sequence comprising a sequence of claim 1 ; (ii) a DNA sequence of interest; and (iii) a gene termination sequence; and

(b) cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth.

9. A method for modifying a phenotype of a target plant, comprising stably incorporating into the genome of the target plant a genetic construct comprising:

(a) a promoter sequence of claim 1 ;

(b) a DNA sequence of interest; and

(c) a gene termination sequence.

10. An isolated polynucleotide comprising a sequence selected from the group consisting of:

(a) complements of the entire length of the sequence recited in SEQ ID NO: 117 or 107; and

(b) reverse complements of the entire length of the sequence recited in SEQ ID NO: 117 or 107.

11. A genetic construct comprising a polynucleotide of claim 10 .

Assignments (4)
SECURITY INTEREST Recorded Mar 31, 2015
From: ARBORGEN INC.
To: NBSC, A DIVISION ON SYNOVUS BANK
Reel/Frame 035348/0921 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME PREVIOUSLY RECORDED ON REEL 031085 FRAME 0871. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT AND THE ASSIGNOR'S CORRECT NAME SHOULD BE ARBORGEN INC. INSTEAD OF ABORGEN INC. Recorded Aug 28, 2013
From: ARBORGEN INC.
To: NBSC, A DIVISION ON SYNOVUS BANK
Reel/Frame 031098/0188 →
SECURITY AGREEMENT Recorded Aug 26, 2013
From: ABORGEN INC.
To: NBSC, A DIVISION OF SYNOVUS BANK
Reel/Frame 031085/0871 →
CHANGE OF NAME Recorded Aug 15, 2013
From: ARBORGEN, LLC
To: ARBORGEN INC.
Reel/Frame 031029/0795 →